Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
NICE Technology Appraisals are mandated for NHS funding, and NHS organisations must normally fund treatments recommended by NICE within three months of guidance publication
Costeffectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States
Synthetic Cyanocobalamin for Reliable Supplementation The active ingredient, cyanocobalamin, is a laboratory-produced form of vitamin B12 that works in the body the same way as naturally occurring vitamin B12 found in fish, seafood, dairy products, and egg yolk
The pooled HR from seven RCTs was 0.79 [95% CI 0.750.83], with low heterogeneity ( I =14%, p=0.32) showing consistent benefits across trials
US$ 21.01
US$ 22.48
US$ 27.30
US$ 21.90
